Table 3.
Prognostic factors for overall survival in surgical resection patients
| Variable | Patients (n = 36) | 1-yr OS | 3-yr OS | 5-yr OS | P value |
| Age (yr) | 0.146 | ||||
| ≤ 60 | 27 | 88.9% | 81.5% | 42.3% | |
| > 60 | 9 | 100% | 88.9% | 66.7% | |
| Gender | 0.245 | ||||
| Male | 34 | 91.2% | 82.4% | 45.1% | |
| Female | 2 | 100% | 100% | 100% | |
| Serum albumin (g/dL) | 0.642 | ||||
| ≤ 3.5 | 10 | 90.0% | 60.0% | 48.0% | |
| > 3.5 | 26 | 92.3% | 87.7% | 46.1% | |
| ALT (IU/L) | 0.593 | ||||
| ≤ 50 | 27 | 92.6% | 81.5% | 53.7% | |
| > 50 | 9 | 88.9% | 71.1% | 23.7% | |
| AST (IU/L) | 0.87 | ||||
| ≤ 50 | 31 | 90.3% | 80.6% | 52.4% | |
| > 50 | 5 | 100% | 100% | 50.0% | |
| ICG R 15 (%) | 0.992 | ||||
| ≤ 14 | 25 | 92.0% | 84.0% | 47.1% | |
| > 14 | 9 | 88.9% | 77.8% | 58.3% | |
| α-fetoprotein | 0.471 | ||||
| ≤ 1000 IU/mL | 32 | 90.6% | 81.3% | 47.3% | |
| > 1000 IU/mL | 4 | 100% | 100% | 50.0% | |
| Cirrhosis | 0.023 | ||||
| No | 16 | 100% | 93.8% | 69.9% | |
| Yes | 20 | 85.0% | 75.0% | 26.5% | |
| Main tumor size (cm) | 0.629 | ||||
| < 3.0 | 17 | 94.1% | 86.3% | 43.1% | |
| ≥ 3.0 | 19 | 89.5% | 73.7% | 52.6% | |
| Number of tumors | 0.061 | ||||
| 2 | 31 | 90.3% | 80.6% | 40.7% | |
| 3 | 5 | 100% | 100% | 100% | |
| Lobar distribution of tumors | 0.892 | ||||
| One lobes | 24 | 91.7% | 83.3% | 49.4% | |
| Two lobe | 12 | 91.7% | 83.3% | 48.6% | |
| Operation type | 0.568 | ||||
| En bloc resection | 23 | 91.3% | 82.6% | 43.4% | |
| Multiple resection or combined with RFA | 13 | 92.3% | 84.6% | 57.1% | |
OS: Overall survival; RFA: Radiofrequency ablation; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ICG R 15: Indocyanine green retention rate at 15.